Medical Management of Dysfunctional Menorrhagia: Is Ormeloxifene a Safe and Efficacious Therapeutic Choice?
Nidhi Gupta
Citation Information :
Gupta N. Medical Management of Dysfunctional Menorrhagia: Is Ormeloxifene a Safe and Efficacious Therapeutic Choice?. J South Asian Feder Menopause Soc 2014; 2 (2):65-70.
Therapeutic use of Levonorgestel releasing intrauterine system in women with menorrhagia. A pilot study. Contraception 2002;65:325-328.
Assessment of menstrual blood loss using a pictoral chart. Br J Obstet Gynaecol 1990; 97:734-739.
Treatment of dysfunctional uterine bleeding. Am enorrhea need not be the end point BMJ 1995;310:802.
Endometrial destruction techniques for heavy menstrual bleeding. Cochrane Database Syst Rev 2005;4:CD001501.
Medical management of abnormal uterine bleeding. Obstet Gynecol Clin North Am 2000;27:287-304.
Treating menorrhagia in primary care: an overview of drug trials and a survey of prescribing practice. Int J Tech Assess Health Care 1995;456-471.
Retrospective valuation of the long-term outcomes following conservative management of menorrhagia in ovulatory women. LSOC Obstet Gynecol Can 1999;2:155-163.
The Levonorgestrel—releasing intrauterine system as an alternative to hysterectomy in perimenopausal women contraception 2007;75:5152-5154.
Optimization of contraceptive dosage regimen of centchromam. Contraception 2001;63:47-51.
A selective estrogen receptor modulator, as a contraceptive and for the management of hormone related clinical disorders. Med Res Rw 2001;21: 303-347.
Centchroman: a nonsteroidal anti cancer agent for advanced breast cancer phase II study. Int J Cancer 1989;43:781-783.
Mode of action of a new nonsteroidal postcoital antifertility agent (centchroman 67/20 CDRI) in rats, Contraception 1974;9:279-289.
Effect of intravaginal instillation of some nonsteroidal oral anti-infertility agent on pregnancy in rats. Ind J Exp Biol 1974;12:370-371.
Management of dysfunctional uterine bleeding. Drugs 1992;44:578-584.
Pharmacokinetics of centchroman in healthy female subjects after oral administration. Contraception 1995;52:297-300.
Treatment of menorrhagia during menstruation. Randomized control trial of ethamsylate, Mefenamic acid and tranexamic acid. BMJ 1996;313:579-582.
A comparison of Flurbiprofen, tranexamic acid and a Levonorgestral releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia. Am J Obstet Gynecol 1991;164:879-883.
Efficacy and safety of ormeloxifene in management of menorrhagia: a pilot study. J Obstet Gynecol Res 2009;35(4):746-752.
Ormeloxifene a selective estrogen receptor modulator, for treatment of dysfunctional menorrhagia. J Obstet Gynecol Ind 2004;54(1):56-59.
Efficacy of a selective estrogen receptor modulator ‘ormeloxifene’ in management of dysfunctional uterine bleeding. J South Asian Fed Obstet Gynec 2010;2(3):207-211.
Contraceptive and noncontraceptive benefits of centchroman. Asian J Obstet Gynecol Practice 1996;1:65-71.
Clinical pharmacokinetics and interaction of centchroman a mini review. Contraception 2010;81(4):275-280.
Selective estrogen receptor modulators (SERMS). Online J Smt NHL Municipal Med Coll. Ahmedabad. Available at: http://www:nhlmmcgym.com/selectiveestrogen.htm.
